Intellectual Property Valuation and Technology Transfer

Possession of a wide breadth of solid intellectual property (IP) is critical for building and maintaining a viable and competitive life sciences company.  However, development of patents and other related IP materials often occurs in university and other academic settings, and often remains underutilized.  In addition, many patents are granted in specific geographies and remain pending in other geographies for long periods of time, leaving gaps in IP strategic plans.  Therefore, technology transfer is a significant component of any product portfolio commercialization strategy.  At tJun17 Life Sciences we have global experience finding both in and out licensing partners for life sciences organizations, including universities, medical device, biotechnology, IVD and specialty pharmaceutical companies anywhere in the world.  We use our extensive network of industry contacts to work with academic organizations and life sciences companies to find licensing or acquisition partners for early stage technologies.  We have a significant record of accomplishment in this area in the US, European, Australian, and Asian markets.  Let us know how we can help you at info@tjun17.com